SCHEMBL23097995

SCHEMBL23097995

Cn1c2ccccc2c2ccc3c4ccccc4n(-c4cncc(-n5c6ccccc6c6ccc7c8ccccc8n(C)c7c65)c4-c4cccc(C#N)c4)c3c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 3/20 0.40
▸ ALKBH5 Q6P6C2 1/20 0.37
▸ FTO Q9C0B1 1/20 0.37
▸ CYP1A2 P05177 3/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ IDO1 P14902 3/20 0.36
▸ CLK4 Q9HAZ1 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928428 0.91 CYP11B2 (0.38) CYP11B2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL21546741 0.90 ALKBH5 (0.40) CYP11B2ALKBH5FTOCYP1A2CYP3A4
SCHEMBL21929241 0.88 ADORA2A (0.38) CYP1A2CYP3A4CYP2D6TSHRIDO1
SCHEMBL23098137 0.88 CYP11B2 (0.39) CYP11B2ALKBH5FTOIDO1ALDH1A1
SCHEMBL21929210 0.85 IDO1 (0.39) CYP1A2CYP3A4CYP2D6TSHRIDO1
SCHEMBL21547035 0.84 KIF11 (0.43) ALKBH5FTOCYP1A2CYP3A4CYP2D6
SCHEMBL21929203 0.84 GABRG2 (0.40) IDO1CLK4ADORA2AGABRA1GABRG2
SCHEMBL21929208 0.84 IDO1 (0.40) CYP1A2CYP3A4CYP2D6TSHRIDO1
SCHEMBL21929014 0.83 IDO1 (0.36) CYP11B2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL21931702 0.83 MAP4K4 (0.41) CYP1A2CYP3A4CYP2D6TSHRIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 — — US disclosed
EP-3609978-B1 ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-03-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA CYP11B2 163/4885ALKBH5 1350/4885FTO 266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback